Experts at UT MD Anderson have numerous presentations throughout the 2026 AACR Annual Meeting. All times listed in Pacific Time.
Experts at UT MD Anderson have numerous presentations throughout the 2026 AACR Annual Meeting. All times listed in Pacific Time.
Friday, April 17
MW01 — AI in cancer care: Practical applications transforming oncology
3–4:30 p.m.
Room 29 | Upper Level Convention Center
Chair introduction
Speaker: Caroline Chung, M.D.
Embracing cancer complexity with data and AI in context
3:01–3:21 p.m.
Speaker: Caroline Chung, M.D.
Saturday, April 18
ED21 — CAR T therapy: Transforming the landscape of adult and pediatric blood cancers
8–9:30 a.m.
Room 6 CF │Upper Level Convention Center
CAR T cell therapy in myeloma: Durability, design and path to functional cure
8:20–8:40 a.m.
Speaker: Krina Patel, M.D.
ED46 — Advances in pre-metastatic niche biology: From pre-clinical insights to clinical opportunities
8–9:30 a.m.
Ballroom 20 AB │Upper Level Convention Center
Disrupting the "soil": Exploring and targeting the pre-metastatic niche
8:31–8:51 a.m.
Speaker: Dihua Yu, M.D, Ph.D.
ED52 — Mapping neural-immune circuits: Spatial multi-omics in the tumor microenvironment
10–11:30 a.m.
Ballroom 6 CF │Upper Level Convention Center
Chair introduction
Speaker: Moran Amit, M.D., Ph.D.
Translating spatial multiomics into clinical action: Integration of spatial, clinical, and population data
11:03–11:16 a.m.
Speaker: Moran Amit, M.D., Ph.D.
MW03 — Bayesian and model-assisted designs for early-phase clinical trials—Simplicity meets efficiency
10–11:30 a.m.
Room 5 │Upper Level Convention Center
Chair/Introduction
Speaker: Ying Yuan, Ph.D.
Bayesian designs for safety and futility monitoring in early-phase clinical trials
11–11:20 a.m.
Speaker: Ying Yuan, Ph.D.
DC01 — Where expedited pathways, innovation, safety and patient access collide: A KRAS case study
12:30–2 p.m.
Room 1 │Upper Level Convention Center
Co-Moderator: Timothy Yap, Ph.D., M.B.B.S.
MW05 — Deep learning in digital pathology: From morphology to multimodal biomarkers
2:30–4 p.m.
Ballroom 6 CF │Upper Level Convention Center
AI pathology meets spatial omics: Decoding tissue architecture for biomarkers
3:30–3:50 p.m.
Speaker: Linghua Wang, M.D, Ph.D.
Sunday, April 19
AOS01 — Advances in bladder cancer research and treatment: Pathways to precision medicine
1–2:30 p.m.
Room 11 | Upper Level Convention Center
Advances in risk stratification and appropriate management of non-muscle invasive bladder cancer
1:05–1:25 p.m.
Speaker: Ashish Kamat, M.D., M.B.B.S.
AOS13 — Gastric/gastroesophageal cancer dynamics: Pre-cancer evolution, metastasis, microenvironment and therapeutic breakthroughs
1–2:30 p.m.
Room 33 | Upper Level Convention Center
Molecular heterogeneity in primary vs metastases and advances in HER2-directed therapeutics
1:50–2:10 p.m.
Speaker: Jaffer Ajani, M.D.
TM04 — PICR-PSWG town hall
6:30–8 p.m.
Room 28 | Upper Level Convention Center
Chair: Paul Scheet, Ph.D.
Monday, April 20
AT06 — Single cell multi-omic technologies for resolving genotype-phenotype relationships in cancer
10:15–11:45 a.m.
Ballroom 6 B │ Upper Level Convention Center
Chair: Nicholas Navin, Ph.D.
Linking genotypes and phenotypes of single cells to decode breast cancer progression
10:15–10:35 a.m.
Speaker: Nicholas Navin, Ph.D.
SY15 — Immunometabolism in cancer
10:15–11:45 a.m.
Room 29 │ Upper Level Convention Center
Reprogramming NK cell metabolism to enhance adoptive cellular therapy
11:10–11:30 a.m.
Speaker: May Daher, M.D.
AOS03 — Microbiota-host interactions in colorectal cancer development and therapy
12:30–2 p.m.
Room 29 │ Upper Level Convention Center
To be determined
1:25–1:45 p.m.
Speaker: Susan Bullman, Ph.D.
SY08 — Does adherence to oral cancer therapy matter?
12:30–2 p.m.
Room 11 │ Upper Level Convention Center
Patient before pill: Strategies for improving outcomes for standard therapies and clinical trials for colorectal cancer
12:56–1:16 p.m.
Speaker: Van Morris, M.D.
SY11 — Cancer vaccines: The next immunotherapy breakthrough?
12:30–2 p.m.
Ballroom 6 A │ Upper Level Convention Center
Mechanisms by which mRNA vaccines augment responses to immune checkpoint blockade
12:55–1:10 p.m.
Speaker: Adam Grippin, M.D., Ph.D.
MG07 — Meet the Editor-in-Chief of Clinical Cancer Research
2–3 p.m.
AACR Publications Booth 3537│Hall BCG
Editor-in-Chief of Clinical Cancer Research
Speaker: Timothy Yap, M.B.B.S., Ph.D.
FO02 — Science of community outreach and engagement: Navigating change and maintaining impact
5–6:30 p.m.
Room 31 │Upper Level - Convention Center
Community engagement as sustainability: The secret sauce for lasting impact
5:20–5:30 p.m.
Speaker: Lorna McNeill, Ph.D.
PDS08 — From hypothesis to headline: publishing your research
5:30–7:30 p.m.
Harbor Ballroom GH │Manchester Grand Hyatt San Diego
Editor-in-Chief of Clinical Cancer Research
6:15–7:00 p.m.
Speaker: Timothy Yap, M.B.B.S., Ph.D.
TM02 — Immune-driven cancer prevention—From vaccines to lifestyle interventions: A CIMM-CPWG town hall and networking meeting
6:30–8 p.m.
Room 30 │Upper Level Convention Center
Invited speaker: Eduardo Vilar-Sanchez, M.D., Ph.D.
Tuesday, April 21
ADT03 — Synthetic lethality in oncology: Progress made, pitfalls encountered and the path forward
10:15–11:45 a.m.
Room 31 │ Upper Level Convention Center
Chair Introduction
Speaker: Timothy Yap, M.B.B.S., Ph.D.
Targeting synthetic lethal paralogs in the clinic: Progress, pitfalls and the promise
10:40–11:00 a.m.
Speaker: Timothy Yap, M.B.B.S., Ph.D.
AOS10 — Turning the tide in the fight against pancreatic cancer
12:30–2 p.m.
Ballroom 6 A │ Upper Level Convention Center
Recent advances in treatment of pancreatic cancer
12:32–12:47 p.m.
Speaker: Shubham Pant, M.D., M.B.B.S.
SY13 — Off-the-shelf cell therapies for cancer and beyond
12:30–2 p.m.
Room 28 │ Upper Level Convention Center
Off-the-shelf NK cell therapies from biology to the clinic
1–1:20 p.m.
Speaker: Katy Rezvani, M.D., Ph.D.
ME01 — Christopher Flowers: Applying molecular classifications to therapy and trials in large b-cell lymphoma
5–5:45 p.m.
Room 5 │ Upper Level Convention Center
Speaker: Christopher Flowers, M.D.
Wednesday, April 22
PL05 — Innovative treatment modalities: Shaping the future of oncology
8–10 a.m.
Ballroom 20 | Upper Level Convention Center
Chair introduction
Speaker: Katy Rezvani, M.D., Ph.D.
Wrap-up and opportunities for the future
9:53–10 a.m.
Speaker: Katy Rezvani, M.D., Ph.D.
ADT08 — Optimizing efficacy while limiting toxicity in immunotherapy for cancer treatment
10:15–11:45 a.m.
Room 28 | Upper Level Convention Center
Migratory vs. tissue-resident leukocytes in checkpoint-induced irAEs
10:41–11:01 a.m.
Speaker: Kristen Pauken, Ph.D.
ADT09 — Targeted therapy frontiers in microsatellite-stable metastatic colorectal cancer
10:15–11:45 a.m.
Room 31 | Upper Level Convention Center
Advances and future strategies for BRAF-mutated CRC
10:20–10:40 a.m.
Speaker: Scott Kopetz, M.D., Ph.D.
AOS12 — Biology and therapeutic targeting of HIF2a in renal cell carcinoma
10:15–11:45 a.m.
Room 15 | Mezzanine Level Convention Center
A paradigm shift in Von Hippel Lindau Syndrome through HIF2a targeting
10:45–11:05 a.m.
Speaker: Eric Jonasch, M.D.
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at UT MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.